# Amphenol Corp: Form 10-Q for the period ended Jun 30, 2014

- Company: [Amphenol Corp](/companies/aph.md) (CIK 820313)
- Form: 10-Q
- Filed: 2014-08-06
- Accepted by EDGAR: Aug 6, 2014, 10:33 ET
- Period: 2014-06-30
- Accession: 0001104659-14-057288
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/820313/000110465914057288/a14-13902_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/820313/000110465914057288/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-04-01 to 2014-06-30 | $1.31bn | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2014-01-01 to 2014-06-30 | $2.56bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-04-01 to 2014-06-30 | $897.4m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2014-01-01 to 2014-06-30 | $1.75bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-04-01 to 2014-06-30 | $416.8m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2014-01-01 to 2014-06-30 | $805.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-04-01 to 2014-06-30 | $161.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2014-01-01 to 2014-06-30 | $315.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-04-01 to 2014-06-30 | $255.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2014-01-01 to 2014-06-30 | $487.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-04-01 to 2014-06-30 | $20.1m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2014-01-01 to 2014-06-30 | $39.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-04-01 to 2014-06-30 | $63.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2014-01-01 to 2014-06-30 | $120.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-04-01 to 2014-06-30 | $176.4m | us-gaap:ProfitLoss |
| Net income | 6 months, 2014-01-01 to 2014-06-30 | $336.2m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2014-04-01 to 2014-06-30 | $1.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2014-01-01 to 2014-06-30 | $2.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-04-01 to 2014-06-30 | $1.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2014-01-01 to 2014-06-30 | $2.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-04-01 to 2014-06-30 | 160,791,135 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2014-01-01 to 2014-06-30 | 160,983,079 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2014-01-01 to 2014-06-30 | $383.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2014-01-01 to 2014-06-30 | $105.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2014-04-01 to 2014-06-30 | $31.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 6 months, 2014-01-01 to 2014-06-30 | $31.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2014-01-01 to 2014-06-30 | $250.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-06-30 | $1.08bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-06-30 | $3.46bn | us-gaap:AssetsCurrent |
| Total assets | at 2014-06-30 | $6.52bn | us-gaap:Assets |
| Current liabilities | at 2014-06-30 | $1.71bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2014-06-30 | $1.54bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-06-30 | $800.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-06-30 | $2.98bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,870 characters.

### Repurchase of Equity Securities

In January 2013, the Company’s Board of Directors authorized a stock repurchase program under which the Company may repurchase up to 10 million shares of its common stock during the two year period ending January 31, 2015 (the “2013 Stock Repurchase Program”). The price and timing of any such purchases under the 2013 Stock Repurchase Program after June 30, 2014 will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, economic and market conditions and stock price. During the six months ended June 30, 2014, the Company repurchased 2.8 million shares of its common stock for approximately $250.2 million. These treasury shares have been retired by the Company and common stock and retained earnings were reduced accordingly. Through July 31, 2014, the Company has repurchased an additional 0.2 million shares of its common stock for $20.0 million. At July 31, 2014, approximately 2.7 million additional shares of common stock may be repurchased under the 2013 Stock Repurchase Program.

| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| January 1 to January 31, 2014 | 693,000 | $86.14 | 693,000 | 5,021,305 |
| February 1 to February 29, 2014 | 709,389 | 85.54 | 709,389 | 4,311,916 |
| March 1 to March 31, 2014 | 8,594 | 86.95 | 8,594 | 4,303,322 |
| April 1 to April 30, 2014 | — | — | — | 4,303,322 |
| May 1 to May 31, 2014 | 1,227,614 | 95.22 | 1,227,614 | 3,075,708 |
| June 1 to June 30, 2014 | 127,200 | 95.40 | 127,200 | 2,948,508 |
| Total | 2,765,797 | $90.45 | 2,765,797 | 2,948,508 |

## Market risk

As filed, 789 characters.

The Company, in the normal course of doing business, is exposed to the risks associated with foreign currency exchange rates and changes in interest rates. There has been no material change in the Company’s assessment of its sensitivity to foreign currency exchange rate risk since its presentation set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in its 2013 Annual Report. As of June 30, 2014, the Company’s average LIBOR rate was 0.15%. A 10% change in the LIBOR interest rate at June 30, 2014 would have no material effect on interest expense. The Company does not expect changes in interest rates to have a material effect on income or cash flows in 2014, although there can be no assurances that interest rates will not significantly change.

## Controls and procedures

As filed, 1,296 characters.

Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the period covered by this report. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and such information is accumulated and communicated to management, including the Company’s principal executive and financial officers, to allow timely decisions regarding required disclosure. There has been no change in the Company’s internal controls over financial reporting during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

## Risk factors

As filed, 134 characters.

There have been no material changes to the Company’s risk factors as disclosed in Part I, Item 1A of the Company’s 2013 Annual Report.

Filed Aug 6, 2014.
Source: SEC EDGAR, the filing index for accession 0001104659-14-057288. Last ingested by Listed: Nov 3, 2026, 18:42 ET. No prices; not investment advice.
